Home/Recalls/CANADA-63956
Health CanadaGeneral Alert

Pfizer recalls Inderal-LA (propranolol hydrochloride) capsules due to a nitrosam...

Published: March 1, 2022Recall ID: 63956Category: generalCountry: Canada

Reason for Recall / Hazard

Contamination

Product Description & Identification

Contact your health care provider to discuss other treatment options, as there are no other companies marketing extended release propranolol in Canada.Continue taking your medication unless you have been advised to stop by your health care provider. Not treating your condition poses a greater health risk.Contact Pfizer Canada ULC at 1-800-463-6001 or www.pfizermedinfo.ca for medical inquiries and at 1-800-387-4974 for general inquiries if you have questions about the recall.Report any health product-related side effects or complaints to Health Canada.

Affected Products

Inderal-LA (propranolol hydrochloride) extended release capsules, in 60 mg, 80 mg, 120 mg and 160 mg strengths

Additional Source Details

FieldValue
N I D63956
U R Lhttps://recalls-rappels.canada.ca/en/alert-recall/pfizer-recalls-inderal-propranolol-hydrochloride-capsules-due-nitrosamine-impurity
IssueContamination
TitlePfizer recalls Inderal-LA (propranolol hydrochloride) capsules due to a nitrosamine impurity
ProductInderal-LA (propranolol hydrochloride) extended release capsules, in 60 mg, 80 mg, 120 mg and 160 mg strengths
Archived0
CategoryDrugs
Last updated2022-03-01
OrganizationCommunications and Public Affairs Branch
What you should doContact your health care provider to discuss other treatment options, as there are no other companies marketing extended release propranolol in Canada.Continue taking your medication unless you have been advised to stop by your health care provider. Not treating your condition poses a greater health risk.Contact Pfizer Canada ULC at 1-800-463-6001 or www.pfizermedinfo.ca for medical inquiries and at 1-800-387-4974 for general inquiries if you have questions about the recall.Report any health product-related side effects or complaints to Health Canada.

Overview

  • Recalling FirmCommunications and Public Affairs Branch
Official Agency Alert